Novartis India

64
Hold
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE234A01025
  • NSEID: NOVARTIND
  • BSEID: 500672
INR
2,047.55
61.15 (3.08%)
BSENSE

Oct 09

BSE+NSE Vol: 53.55 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is -0.54% vs 6.33% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 2.93% vs 40.09% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is 63.64% vs -48.32% in Mar 2025

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2026 is -7.65% vs 18.44% in Mar 2025

Compare Profit and Loss Results of Novartis India
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
354.00
2,126.00
-1,772.00
-83.35%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
354.00
2,126.00
-1,772.00
-83.35%
Expenditure (Ex Depriciation)
Stock Adjustments
-12.00
11.00
-23.00
-209.09%
Raw Materials Consumed
210.00
677.00
-467.00
-68.98%
Power & Fuel Cost
0.00
43.00
-43.00
-100.00%
Employee Cost
21.00
476.00
-455.00
-95.59%
Operating Expenses
9.00
166.00
-157.00
-94.58%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
11.00
193.00
-182.00
-94.30%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
6.00
30.00
-24.00
-80.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
260.00
1,774.00
-1,514.00
-85.34%
Operating Profit (PBDIT) excl Other Income
94.00
352.00
-258.00
-73.30%
Other Income
38.00
111.00
-73.00
-65.77%
Operating Profit (PBDIT)
132.00
463.00
-331.00
-71.49%
Interest
1.00
4.00
-3.00
-75.00%
Profit before Depriciation and Tax
131.00
458.00
-327.00
-71.40%
Depreciation
1.00
59.00
-58.00
-98.31%
Profit Before Taxation & Exceptional Items
129.00
399.00
-270.00
-67.67%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
129.00
378.00
-249.00
-65.87%
Provision for Tax
36.00
92.00
-56.00
-60.87%
Profit After Tax
93.00
285.00
-192.00
-67.37%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
768.00
1,948.00
-1,180.00
-60.57%
Profit Available for appropriations
862.00
2,233.00
-1,371.00
-61.40%
Appropriations
862.00
2,233.00
-1,371.00
-61.40%
Equity Dividend (%)
500%
500%
0.00
Earnings Per Share
37.74
17.56
20.18
114.92%
Profit And Loss - Net Sales
Net Sales 354.33 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -0.54% vs 6.33% in Mar 2025

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 94.10 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 2.93% vs 40.09% in Mar 2025

Profit And Loss - Interest
Interest 1.26 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 63.64% vs -48.32% in Mar 2025

Profit And Loss - Profit After Tax
Profit After Tax 93.18 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -7.65% vs 18.44% in Mar 2025